Abstract
Objective: This study explored the therapeutic outcomes of psychodynamic psychotherapy for Major depressive disorder (MDD) in comparison with pharmacotherapy.
Methods: The focus of psychodynamic psychotherapy was on the superego pathology and its developmental backgrounds, while pharmacotherapy was done using SSRIs. A sample of 50 MDD patients was randomly selected by clinical interview using DSM-IV-TR. The presence and severity of the depressive symptoms were assessed using the MMPI-2 depression content scale as a symptom checklist, and the Beck Depression Inventory. Twenty five patients were selected for the psychoanalytic psychotherapy group and twenty five patients for pharmacotherapy. After 15 weeks, all the participants were assessed using the same instruments.
Results:The results indicated a comparable symptom reduction in the two groups.
Conclusion: Clinical observations confirmed the psychodynamic inferences about the role of the superego pathology in MDD.
Declaration of Interest: None.
Clinical Trial Registration: URL: http://www.irct.ir/ Unique identifier: IRCT201011032935N5
Citation: Rahmani F, Rezaei F, Nasuri M. Major depressive disorder: A comparison of a focused psychodynamic psychotherapy and pharmacotherapy. Iranian Journal of Psychiatry and Behavioral Sciences 2011; 5(1): 37-44.
Keywords
Major Depressive Disorder Psychodynamic Psychotherapy Pharmacotherapy
Fulltext
Full text is available in the PDF.
References
-
1.
References are available in the PDF.
Copyright
© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.